Iron-dependent ferroptosis, a non-apoptotic cell death mechanism, is gaining attention for its role in immune suppression.

Technological advancements over the past few decades have unraveled the diversity and adaptability of tumors, shedding light ...

NEW YORK - A Ludwig Cancer Research study has identified a key barrier to the efficacy of a promising combination of ...

Gastrointestinal (GI) cancers, such as colorectal, gastric, and pancreatic cancers, are among the most prevalent and deadly ...

Scientists are developing novel nanoparticles that could dramatically increase the effectiveness of immunotherapies when ...

University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggressive form of breast cancer.

BDC-3042 Phase 1 clinical trial fully enrolled the highest dose cohort with no dose-limiting toxicities (DLTs), results will ...

Researchers in Australia are developing next-generation nanoparticles to supercharge current treatments for triple-negative ...

SAN DIEGO and SUZHOU, China, March 24, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and ...

Vicero, Inc., a preclinical-stage biopharmaceutical company developing next-generation VINCOBODIES for immune-mediated diseases, today announced the appointment of two distinguished oncologists and ...